UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 10.

Hundsberger, T; Hottinger, A F; Roelcke, U; Roth, P; Migliorini, D; Dietrich, P Y; Conen, K; Pesce, G; Hermann, E; Pica, A; Gross, M W; Brügge, D; Plasswilm, L; Weller, M; Putora, P M (2016). Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. Journal of Neuro-Oncology, 126(1):175-183.

Korfel, A; Thiel, E; Martus, P; Möhle, R; Griesinger, F; Rauch, Mi; Röth, A; Hertenstein, B; Fischer, T; Hundsberger, T; Mergenthaler, H G; Junghanß, C; Birnbaum, T; Fischer, L; Jahnke, K; Herrlinger, U; Roth, P; Bamberg, M; Pietsch, T; Weller, M (2015). Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma. Neurology, 84(12):1242-1248.

Hundsberger, T. Behandlungsstrategien bei rezidivierenden Gliomen des Erwachsenenalters. 2014, University of Zurich, Faculty of Medicine.

Hundsberger, T; Roth, P; Roelcke, U (2014). Neurologische Komplikationen bei onkologischen Patienten. Praxis, 103(17):1009-1016.

Hundsberger, T; Tonder, M; Hottinger, A; Brügge, D; Roelcke, U; Putora, P M; Stupp, R; Weller, M (2014). Clinical management and outcome of histologically verified adult brainstem gliomas in Switzerland: a retrospective analysis of 21 patients. Journal of Neuro-Oncology, 118(2):321-328.

Seystahl, K; Wiestler, B; Hundsberger, T; Happold, C; Wick, W; Weller, M; Wick, A (2013). Bevacizumab Alone or in Combination with Irinotecan in Recurrent WHO Grade II and Grade III Gliomas. European Neurology, 69(2):95-101.

Hundsberger, T; Roth, P (2013). Neuroonkologie – ASCO 2013: Erst- und Rezidivbehandlung von Glioblastomen – Ernüchterung durch negative Phase-III-Studien. Leading Opinions Neurologie & Psychiatrie:1-3.

Korfel, A; Weller, M; Martus, P; Roth, P; Klasen, H A; Roeth, A; Rauch, M; Hertenstein, B; Fischer, T; Hundsberger, T; Leithäuser, M; Birnbaum, T; Kirchen, H; Mergenthaler, H G; Schubert, J; Berdel, W; Birkmann, J; Hummel, M; Thiel, E; Fischer, L (2012). Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial. Annals of Oncology, 23(9):2374-2380.

Gautschi, O P; Cadosch, D; Collen, T D; Land, M; Hoederath, P; Hildebrandt, G; Fournier, J Y; Hundsberger, T (2010). Glioblastoma multiforme - Neue Hoffnungen dank moderner Therapieansätze. Praxis, 99(5):295-308.

Thiel, E; Korfel, A; Martus, P; Kanz, L; Griesinger, F; Rauch, M; Roth, A; Hertenstein, B; von Toll, T; Hundsberger, T; Mergenthaler, H G; Leithäuser, M; Birnbaum, T; Fischer, L; Jahnke, K; Herrlinger, U; Plasswilm, L; Nägele, T; Pietsch, T; Bamberg, M; Weller, M (2010). High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial. Lancet Oncology, 11(11):1036-1047.

This list was generated on Fri Jul 28 04:54:17 2017 CEST.